SCHEMBL7651794

SCHEMBL7651794

O=[C]c1cccc(C(=O)c2ccc([N+](=O)[O-])cc2)c1/C=C/c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.45
MAOB P27338 6/20 0.44
BCHE P06276 1/20 0.44
CYP1B1 Q16678 1/20 0.44
SNCA P37840 1/20 0.43
MAOA P21397 3/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HSP90AA1 P07900 1/20 0.42
NR2F2 P24468 1/20 0.42
ADAM17 P78536 1/20 0.42
PTGS2 P35354 2/20 0.42
POLB P06746 1/20 0.42
MAPK1 P28482 1/20 0.42
PTGS1 P23219 1/20 0.42
SRD5A2 P31213 1/20 0.41
HSPD1 P10809 1/20 0.41
HSPE1 P61604 1/20 0.41
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7720997 0.81 PTGS2 (0.46) CYP19A1MAOBBCHECYP1B1SNCA
SCHEMBL7720996 0.81 PTGS2 (0.46) CYP19A1MAOBBCHECYP1B1SNCA
SCHEMBL9760328 0.78 MAPK1 (0.47) MAOBMAOALMNAMAPTALDH1A1
SCHEMBL7655049 0.78 BCHE (0.50) CYP19A1MAOBBCHECYP1B1SNCA
SCHEMBL10416822 0.78 MAPK1 (0.43) LMNAMAPTALDH1A1POLBMAPK1
SCHEMBL7651789 0.76 SNCA (0.44) CYP19A1MAOBBCHECYP1B1SNCA
SCHEMBL8386280 0.74 MEN1 (0.44) CYP19A1MAOBBCHECYP1B1SNCA
SCHEMBL8471201 0.70 ALDH1A1 (0.51) MAOBMAOALMNAMAPTALDH1A1
SCHEMBL9134846 0.69 TDP1 (0.78) MAOBBCHECYP1B1MAOAMAPT
SCHEMBL9134841 0.69 TDP1 (0.78) MAOBBCHECYP1B1MAOAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6491903-B1 NARROW MOLECULAR WEIGHT DISTRIBUTION SHELL-CORE POLYMERS HAVING HYDROPHILIC, CROSSLINKED PERMEABLE SHELLS AND HYDROPHOBIC CORES, USED FOR REDUCING BLOOD CHOLESTEROL AND BILE ACID UPTAKE IN INTERSTINES; DRUG DELIVERY WASHINGTON UNIVERSITY 2002-12-10 US disclosed